Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Peak Bio Inc (CE) | PKBO | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0085 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0085 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.002 - 1.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0085 | USD |
Peak Bio Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 171.66k | 20.20M | 2.71M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Peak Bio (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/05/2024 | 15:51 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
| 3/05/2024 | 15:48 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 08:17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/06/2024 | 15:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/29/2024 | 16:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/03/2024 | 16:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/22/2023 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/16/2023 | 15:02 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 11/02/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/28/2023 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 9/28/2023 | 15:05 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of.. |
| 9/19/2023 | 15:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PKBO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0085 | 0.0085 | 0.0085 | 0.0085 | 300 | 0.00 | 0.00% |
| 1 Month | 0.0085 | 0.0085 | 0.0085 | 0.0085 | 300 | 0.00 | 0.00% |
| 3 Months | 0.002 | 0.0085 | 0.002 | 0.0023945 | 3,272 | 0.0065 | 325.00% |
| 6 Months | 0.0799 | 0.26465 | 0.002 | 0.0747803 | 5,291 | -0.0714 | -89.36% |
| 1 Year | 0.7989 | 1.00 | 0.002 | 0.2154987 | 12,541 | -0.7904 | -98.94% |
| 3 Years | 5.00 | 5.00 | 0.002 | 0.4806327 | 11,279 | -4.99 | -99.83% |
| 5 Years | 5.00 | 5.00 | 0.002 | 0.4806327 | 11,279 | -4.99 | -99.83% |
Peak Bio (CE) Description
| The company is a clinical-stage biopharmaceutical company focused on commercializing innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare and specialty diseases and cancer. |
